![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
| Item Type: | Review |
|---|---|
| Title: | Recent technological updates and clinical applications of induced pluripotent stem cells |
| Creators Name: | Diecke, S., Jung, S.M., Lee, J. and Ju, J.H. |
| Abstract: | Induced pluripotent stem cells (iPSCs) were first described in 2006 and have since emerged as a promising cell source for clinical applications. The rapid progression in iPSC technology is still ongoing and directed toward increasing the efficacy of iPSC production and reducing the immunogenic and tumorigenic potential of these cells. Enormous efforts have been made to apply iPSC-based technology in the clinic, for drug screening approaches and cell replacement therapy. Moreover, disease modeling using patient-specific iPSCs continues to expand our knowledge regarding the pathophysiology and prospective treatment of rare disorders. Furthermore, autologous stem cell therapy with patient-specific iPSCs shows great propensity for the minimization of immune reactions and the provision of a limitless supply of cells for transplantation. In this review, we discuss the recent updates in iPSC technology and the use of iPSCs in disease modeling and regenerative medicine. |
| Keywords: | Induced Pluripotent Stem Cells, Reprogramming Technique, Gene Editing, Disease Model, Regenerative Medicine, Animals, Mice |
| Source: | Korean Journal of Internal Medicine |
| ISSN: | 1226-3303 |
| Publisher: | Korean Assoc Internal Medicine |
| Volume: | 29 |
| Number: | 5 |
| Page Range: | 547-57 |
| Date: | September 2014 |
| Official Publication: | https://doi.org/10.3904/kjim.2014.29.5.547 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
